Aitana Balaguer-Rosello

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Timing of Allogeneic Hematopoietic Cell Transplantation After Inotuzumab Ozogamicin Influences Sinusoidal Obstruction Syndrome and Survival in Relapsed/Refractory B-ALL.

Timing of Allogeneic Hematopoietic Cell Transplantation After Inotuzumab Ozogamicin Influences Sinusoidal Obstruction Syndrome and Survival in Relapsed/Refractory B-ALL.

Journal: Transplantation and cellular therapy

Published: June 15, 2026

Secondary Malignancies after Hematopoietic Stem Cell Transplantation.

Secondary Malignancies after Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: March 16, 2026

Secondary Malignancies After Hematopoietic Stem Cell Transplantation.

Secondary Malignancies After Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: March 16, 2026

Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee.

Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee.

Journal: Bone marrow transplantation

Published: March 06, 2026

Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.

Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.

Journal: Bone marrow transplantation

Published: March 06, 2026

Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party.

Haematopoietic stem cell transplantation in hepatosplenic T-cell lymphoma: a retrospective analysis of the EBMT Lymphoma Working Party.

Journal: The Lancet. Haematology

Published: December 28, 2025

Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.

Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.

Journal: Transplantation and cellular therapy

Published: November 12, 2025

Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.

Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.

Journal: British journal of haematology

Published: October 02, 2025

Chronic graft-versus-host disease in the era of posttransplant cyclophosphamide.

Chronic graft-versus-host disease in the era of posttransplant cyclophosphamide.

Journal: Haematologica

Published: September 28, 2025

Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation.

Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation.

Journal: International journal of dermatology

Published: September 16, 2025

Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC Study.

Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC Study.

Journal: Blood advances

Published: August 20, 2025

Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT.

Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT.

Journal: EClinicalMedicine

Published: August 13, 2025

Showing 1-12 of 60

Last Updated: 09/26/2026